Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies
Lance H. Rodan(Boston Children's Hospital), Pankaj B. Agrawal(Post Graduate Institute of Medical Education and Research), Gerard T. Berry(Boston Children's Hospital), Alissa M. D’Gama(Boston Children's Hospital), Siqi Cao(Boston Children's Hospital), Edward Yang(Insper), Marissa Hauptman(Boston Children's Hospital), Marianne Wessling‐Resnick(Harvard University), Andrea Gropman(Children's National), Susan J. Hayflick(Institut Necker Enfants Malades), Anita Qualls(Boston Children's Hospital), Jozef Hertecant(Tawam Hospital), Karin Tuschl(University College London), Fatma Al‐Jasmi(United Arab Emirates University), Alan D. Woolf(Boston Children's Hospital)
Cited by 50
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
|Cell|2012|598